Endothelial dysfunction associated with oxidative stress in human.

The imbalance in pro- and anti-oxidant activity causes endothelial dysfunction, which precedes and exacerbates atherosclerosis. LDL-apheresis improves ischemic symptom in patients with hypercholesterolemia and regresses atherosclerosis. Whereas, patients who undergo hemodialysis experience accelerated atherosclerosis and premature death even though their cholesterol level is known to be normal. We investigated the association between oxidative modification and endothelial function during a single session of blood purification therapies, LDL-apheresis and hemodialysis. To examine the effect of a single session of LDL-apheresis on endothelial function in patients with hypercholesterolemia, we measured forearm blood flow (FBF) by strain gauge plethysmography before and after LDL-apheresis, while infusing acetylcholine (ACh) and sodium nitroprusside (SNP). The single session of LDL-apheresis reduced oxidized-LDL. Although ACh and SNP increased FBF dose-dependently before and after LDL-apheresis, ACh response was significantly augmented without changes in responses to SNP. The plasma level of oxidized LDL correlated with the degree of ACh-induced vasodilatation. To examine the effect of a single session of hemodialysis on endothelial function in patients with end stage renal disease, we estimated flow-mediated vasodilation (FMD) during reactive hyperemia using a high-resolution ultrasonography, before and after a single session of hemodialysis. We also investigated the effect of anti-oxidative modification during hemodialysis using an a-tocopherol acetate-coated or a non-coated cellulose dialyzer. Non-specific endothelium independent vasodilation was measured after sublingual glyceryltrinitrate spray (GTN; 0.3 mg) administration in each session. A single session of hemodialysis increased plasma level of oxidized LDL. Although hemodialysis treatment did not affect GTN-induced vasodilation, a single session of hemodialysis impaired the endothelium-dependent vasodilation. Treatment with vitamin E-coated-dialyzer restored endothelium-dependent vasodilation, which was accompanied by decrease in oxidized LDL. Thus, endothelial function was impaired by acute increase in oxidative stress and was restored by anti-oxidant therapy. Our results suggest the importance of controlling oxidative stress in addition to classical risk factors to preserve human endothelial function.

[1]  D. Pongratz,et al.  Mitochondrial angiopathy in a family with MELAS. , 1992, Neuropediatrics.

[2]  E. Stier,et al.  Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  N. Hoenich Platelet and leucocyte behaviour during haemodialysis. , 1999, Contributions to nephrology.

[4]  E. Schon,et al.  Analysis of cybrids harboring MELAS mutations in the mitochondrial tRNALeu(UUR) gene , 1995, Muscle & nerve. Supplement.

[5]  M. Leichsenring,et al.  Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. , 1996, Kidney international.

[6]  T. Coffman,et al.  Angiotensin‐II receptors: new targets for antihypertensive therapy , 1997, Clinical cardiology.

[7]  P. Vallance,et al.  Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. , 1999, Cardiovascular research.

[8]  T. Lüscher,et al.  Biology of the Endothelium , 1997, Clinical cardiology.

[9]  D. Harrison,et al.  Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.

[10]  I. Nonaka,et al.  Findings in muscle in complex I (NADH coenzyme Q reductase) deficiency , 1988, Annals of neurology.

[11]  J. Cooke,et al.  Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. , 1999, Circulation.

[12]  D. Collen,et al.  Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. , 1998, Atherosclerosis.

[13]  M. Thomas,et al.  Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E, and iron status. , 1994, Free radical biology & medicine.

[14]  J. Loscalzo,et al.  Homocysteine and atherothrombosis. , 1998, The New England journal of medicine.

[15]  T. Imaizumi,et al.  Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. , 2000, Circulation.

[16]  B. Halliwell,et al.  Biologically relevant metal ion‐dependent hydroxyl radical generation An update , 1992, FEBS letters.

[17]  M. Miyata,et al.  Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. , 1995, Circulation.

[18]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  D. Bagchi,et al.  Oxidative mechanisms in the toxicity of metal ions. , 1995, Free radical biology & medicine.

[20]  J. Keaney,et al.  Antioxidants and atherosclerotic heart disease. , 1997, The New England journal of medicine.

[21]  J. Himmelfarb,et al.  Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. , 1997, Journal of the American Society of Nephrology : JASN.

[22]  G. Eknoyan,et al.  Cardiovascular disease in chronic renal disease. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  Daniel Steinberg,et al.  Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.

[24]  T. Imaizumi,et al.  Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. , 1999, Clinical science.

[25]  L. Chiarantini,et al.  Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. , 1998, Kidney international.

[26]  M. Gertler,et al.  Ischemic Heart Disease: Insulin, Carbohydrate, and Lipid Interrelationships , 1972, Circulation.

[27]  U. Förstermann,et al.  Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III) , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  R. Sakuta,et al.  Vascular involvement in mitochondrial myopathy , 1989, Annals of neurology.

[29]  T. Lüscher,et al.  Atherosclerosis and the two faces of endothelial nitric oxide synthase. , 1998, Circulation.

[30]  T. Imaizumi,et al.  Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. , 1997, Circulation.

[31]  S. Melov,et al.  Mitochondrial disease in mouse results in increased oxidative stress. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Kugiyama,et al.  Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins , 1990, Nature.

[33]  J. Marx,et al.  Iron, atherosclerosis, and ischemic heart disease. , 1999, Archives of internal medicine.

[34]  C. Ronco,et al.  Vitamin E-bonded membrane : a further step in dialysis optimization , 1999 .

[35]  T. Tatemichi,et al.  Cerebral Hyperemia in MELAS , 1994, Stroke.

[36]  H. Drexler,et al.  Endothelial dysfunction: clinical implications. , 1997, Progress in cardiovascular diseases.

[37]  D. Stuehr Structure-function aspects in the nitric oxide synthases. , 1997, Annual review of pharmacology and toxicology.

[38]  T. Imaizumi,et al.  Tetrahydrobiopterin restores endothelial function in long-term smokers. , 2000, Journal of the American College of Cardiology.

[39]  J. Sullivan The iron paradigm of ischemic heart disease. , 1989, American heart journal.

[40]  J. Heinecke Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. , 1998, Atherosclerosis.

[41]  J P Cooke,et al.  Nitric oxide synthase: role in the genesis of vascular disease. , 1997, Annual review of medicine.

[42]  D. Celermajer,et al.  Endothelial dysfunction: does it matter? Is it reversible? , 1997, Journal of the American College of Cardiology.